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Mineralocorticoid Receptor (MR) activation induces the expression of
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in dendritic cells
in vitro and during the aldosterone-dependent hypertension
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Centre de Recherches des Cordeliers, Paris, France
Introduction: Inadequate activation of the Mineralocorticoid Receptor
(MR) promotes hypertension, inflammation and fibrosis. Neutrophil Gelati-
nase-Associated Lipocalin (NGAL), a pro-inflammatory/fibrotic glycoprotein,
is a target of MR-genomic upregulation in cardiovascular cells, and is
increased in immune cells during inflammation. Recently, we have demon-
strated that NGAL is crucial for hypertensive effects of aldosterone-salt
(NAS) challenge in mice. The specific cell types that modulate the NGAL
production during Aldosterone (Aldo)-dependent hypertension are unknown.
The aim was to characterize the NGAL expression in mouse immune cells,
and to study the effect of MR activation on the NGAL and pro-inflammatory
cytokines expression in dendritic cells (DCs).
Methods: Male C57Bl6 mice were treated in groups Sham and NAS
(200μg/kg/d, 28 days). Peripheral blood mononuclear cells (PBMC) were iso-
lated, and CD4+, CD8+ T cells, B cells, DCs and Macrophages (Mø) were
sorted from spleen. DCs and Mø were cultured from WT and NGAL-KO mice
and treated with Aldo (100nM) or vehicle for 24hrs. NGAL and cytokines
mRNAs abundance was measured by qRT-PCR.
Results: NAS mice presented high systolic blood pressure (123 mmHg vs.
Sham 101±6 mmHg, p<0.05), cardiac and renal hypertrophy. Additionally,
NAS treatment induced a selective increase in the recruitment of activated-
CD8+ cells, B cells and granulocytes in lymph nodes. NGAL abundance was
higher in PBMC, DCs and Mø, which were further increased in NAS mice
(<3-fold vs. Sham, p<0.05 mRNA). In vitro MR activation by Aldo in DCs,
but not in Mø, induced an upregulation of NGAL and of cytokines involved
in the adaptive immune response: TGF-β1 and IL-23p19 (n=4, p<0.05). Inter-
estingly, the NGAL absence in DCs prevented this overexpression.
Conclusion: The MR activation and their subsequent NGAL induction in
DCs could play a pivotal role in the inflammation observed during the Aldo-
dependent hypertension.
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Background: High blood pressure is one of the most important modifiable
risk factors for cardiovascular disease; the prevalence of hypertension in
Moroccan population is 33.6% 
Hypertension is a complex, multifactorial and may be triggered by the
genetic and environmental factors.
The heritable component of blood pressure has been documented in familial
and twin studies suggesting that 30%-50% of the variance of blood pressure
readings are attributable to genetic heritability and also to environmental fac-
tors.
Methods: A total of 101 patients with hypertension were included and
stratified by cardiovascular risk. We studied the genetic variability of two
genes: the MTHFR gene (C677T) involved in vascular factors and the ACE
gene (I / D) which is part of the renin-angiotensin-aldosterone system.
Results: 33.66% of our population (gender confused) had a higher risk,
40.59% had a medium risk, while 25.75% had a low risk. Concerning the
genetic study, we found an allele frequency (D) of ACE gene of 84.2%
without susceptibility to hypertension whatever the genotype (p = 0.3 and 0.1
genotypes ID and DD, respectively) and a gene frequency (T) of 53.5% of the
MTHFR gene with a statistically significant surisque of homozygous mutant
TT (p = 0.042). 
Conclusion: The D allele of the ACE gene is not correlated with hyper-
tension predisposition while the T allele of the MTHFR gene is associated
with hypertension in its homozygous form.
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Exome sequencing in seven families and gene-based association stu-
dies indicate genetic heterogeneity and suggest possible candidates for
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Fibromuscular dysplasia (FMD) is a nonatherosclerotic vascular disease
leading to stenosis, aneurysm and dissection, mainly of renal arteries and
carotids. FMD occurs predominantly in females with ~4/1000 prevalence and
cause hypertension, renal ischemia or stroke. The pathogenesis of FMD is
unknown and a genetic origin is suspected given its demonstrated familial
aggregation. We performed whole exome sequencing (WES) in 16 cases
(seven families). Coding variants in 3,971 genes were prioritized on frequency
(minor allele frequency <0.01) and in silico predicted functionality. No gene
harbors variants that are shared among all affected members of at least three
families. Variants from 16 genes of vascular and connective tissue diseases are
excluded as causative in these families. Genes with at least four variants in the
16 patients and vascular genes were followed-up using genotypes from 249
unrelated cases and 689 controls. Gene-based association analyses using
SKAT-O shows nominal significant association with multifocal FMD
(N=164) for myosin light chain kinase (MYLK, P=0.01) previously involved
in thoracic aortic aneurysm, obscurin (OBSCN), a sarcomeric protein
(P=0.003), dynein cytoplasmic heavy chain 1 (DYNC2H1, P=0.02) and
RNF213 previously associated with Moyamoya disease (P=0.01). Our study
indicates genetic heterogeneity and the unlikely existence of a major gene for
FMD and excludes the role of several vascular genes in familial FMD. We
also suggest four possible candidate genes for multifocal FMD, though these
findings need further genetic and functional confirmation. More powerful
WES and association studies (e.g. GWAS) will better decipher the genetic
basis of FMD.
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Women, before menopause, are less affected than men by hypertension and
atherosclerosis, the main causes of cardiovascular diseases. Estrogens have
been shown to protect the vascular endothelium through their nuclear recep-
tors, mainly via the estrogen receptor alpha (ERα). However, recent studies
have shown that a fraction of ERα is located at the cell membrane where it
initiates a Membrane Initiated Steroid Signaling (MISS). Both membrane and
nuclear pathways of ERα play a protective role in endothelial cells but their
respective role in hypertension is unknown. To investigate the protective
effects of ERα in hypertension, we used (i) mice lacking ERα (ERα-/-), (ii)
mice with a point mutation of the palmitoylation site of ERα (C451A-ERα)
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to obtain membrane-specific loss of function (iii) mice lacking the AF2
ligand-dependant-transcriptional function domain of ERα (AF2°) and (iv)
wild type (WT) mice. Hypertension was induced using Angiotensin II (Alzet
minipumps) and blood pressure measured using tail cuff. After 28 days vas-
cular structure and function were measured in vitro. Angiotensin II-induced
hypertension was greater in ERα-/- and in AF2° mice than in WT and C451A-
ERα mice. These data suggest that the protective effect of ERα against ele-
vated blood pressure involved nuclear AF2-mediated transcriptional functions
rather than MISS-mediated function. Changes in pressure were associated
with proportional changes in endothelium-dependent dilation and wall thick-
ness. Thanks to this work, we hope to better understand how ERα is able to
mediate the protective effects of estrogen against hypertension.
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Extracellular nucleotides are responsible for pleiotropic effects in the vas-
culature. Uracyl nucleotides are vasoactive and trophic agents and promote
inflammation. The participation of specific P2 receptors in these effects
remains undefined and their potential contribution in arterial hypertension is
unknown. Objective: To evaluate the contribution of the UDP receptor P2Y6
in hypertension in mouse. Methods: Arterial contraction was evaluated using
a wire myograph. Blood pressure was measured following nucleotides iv infu-
sion and experimental hypertension was induced either by Angiotensine-II
(Ang-II 1mg/kg/j) or DOCA-salt (1%) in uni-nephrectomized mice. Histolog-
ical approaches, immunofluorescence and RTqPCR were used to evaluate the
nature of vascular remodeling. Results: P2Y6 displayed the highest arterial
expression level among other P2Y receptors. Contraction of conductance (tho-
racic aorta) and resistance (mesenteric) arteries was abrogated in P2ry6-/-
mice in response to UDP and UTP while other vasoconstrictor induced normal
responses. P2Y6 receptor triggered a moderated intracellular calcium increase
while RhoA (calcium facilitating pathway) activation was abrogated in P2ry6-
/- mice. Both genetic deletion and pharmacological blockade of P2Y6 receptor
abolished Ang-II-induced blood pressure increase (40 mmHg in wild type
mice). By contrast, hypertensive response in DOCA-salt was equivalent in
both genotypes. Following Ang-II treatment, P2ry6-/- mice developed a
reduced arterial hypertrophic remodeling and fibrosis but equivalent immune
cell recruitment/infiltration compared to wild type. These changes were cor-
roborated to reduced mRNA expressions of TGFβ and NADPH oxidase sub-
units. Conclusions: Vascular P2Y6 receptor contributes to exaggerated
vascular tone, hypertrophy and fibrosis in the context of Ang-II-dependent
hypertension. Its absence or pharmacological blockade limits vascular
damages and prevents blood pressure increase associated to hypertension.
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Beside calcification, the impact of ABCC6 deficiency on the vasculature
remains unclear. We investigated arterial structure and function in Abcc6-/-
mice, a model of the human Pseudoxanthoma Elasticum (PXE). Arterial cal-
cium accumulation determined by atomic absorption spectrometry was 1.5 –
to 2-fold higher in Abcc6-/- than in wild-type mice. Calcium also accumulated
locally leading to a specific punctuated pattern. Abcc6-/- mesenteric arteries
mounted on a wire myograph displayed slight increase in arterial vaso-
constrictor tone in response to phenylephrine and thromboxane A2. Interest-
ingly, myogenic tone (Bayliss effect) determined using a pressure myograph
was significantly elevated in Abcc6-/- compared to wild type arteries. Arterial
blood pressure was not significantly modified in Abcc6-/- animals, despite
higher variability. These changes were accompanied with deregulated gene
expression (RTqPCR) in both liver and resistance arteries. Old Abcc6-/-
mouse mesenteric arteries expressed markers of both osteogenic (Runx2, opn)
and chondrogenic lineage (Sox9, col2a1). Surprisingly Enpp1 and Alpl genes
encoding ectonucleotide pyrophosphatase/phosphodiesterase 1 and alkaline
phosphatase were deregulated within Abcc6-/- liver and this was corroborated
with reduced alkaline phosphatase circulating levels in PXE patients. As a
conclusion, scattered calcium depositions result from osteochondrogenic trans-
differentiation of vascular cells. The lower elasticity and increased myogenic
tone evidenced in aged Abcc6-/- mice suggest a reduced control of local blood
flow, which in turn may alter vascular homeostasis. Our findings argue in
favor of a deregulated arterial function and may help to decipher conse-
quences of ABCC6 deficiency since PXE is a significant risk factor for small
vessel disease and particularly ischemic stroke.
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Objective: The hypothesis that hypertension confers a hypercoagulable
state arises from the complications associated with hypertension, stroke and
myocardial infarction. Our objective was to determine whether spontaneous
hypertension causes changes in the thrombin generating capacity of the vas-
cular wall.
Approach and Results: We used spontaneously hypertensive rats (SHR)
compared with Wistar rats. The addition of thoracic aorta rings of SHR to a
Wistar or SHR plasma pool resulted in a greater increase in thrombin genera-
tion compared to the addition of equivalent rings from Wistar. Comparison of
5 week-old and 12 week-old rats indicate that established hypertension is
required to induce increased thrombin generation within the vessel wall.
Whereas no difference was observed for endothelial cells, thrombin formation
was higher at the surface of cultured aortic smooth muscle cells (SMCs) from
SHR than from Wistar. Exposure of negatively-charged phospholipids was
higher on SHR than on Wistar aortic rings as well as on SMCs. Tissue factor
activity was higher in SHR SMCs. Twelve week-old SHR exhibited acceler-
ated FeCl3-induced thrombus formation in carotid arteries and the resulting
occlusive thrombi are disaggregated by blockade of glycoprotein Ibα-von
Willebrand factor interactions. SHR SMCs were more sensitive to thrombin-
induced proliferation than Wistar SMCs. This cellular effect was totally
abolished by a protease-activated receptor 1 inhibitor.
Conclusions: The prothrombotic phenotype of the SHR vessel wall was
due to the ability of SMCs to support greater thrombin generation and resulted
in accelerated occlusive thrombus formation after arterial injury, which is sen-
sitive to glycoprotein Ibα-von Willebrand factor inhibitors.
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The renin-angiotensin system has a key role in cardiovascular homeostasis,
mainly through activation of angiotensin II type 1 (AT1R) and type 2 (AT2R)
